Assure’s case volume for the full year is expected to grow by more than 40 percent, the company said Aug. 15. It expects a positive adjusted EBITDA in the second half of the year.
The company saw a second quarter net loss of $4.7 million, and a net loss per diluted share of $0.37, both steeper losses than over the same period in 2021.
“Given recent economic and capital markets uncertainty, Assure began a strategic cost-reduction effort that we expect will yield over $4.5 million of annualized savings,” Assure’s CEO and executive chair John Farlinger said in a company call. “As a result, we expect to become cash flow positive on an adjusted operating basis in the second half of 2022.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
